Qualigen Therapeutics(US:QLGN) Sou Hu Cai Jing·2025-09-21 10:26Group 1 - Faraday Future announced a strategic investment in Nasdaq-listed QLGN, which will be renamed CXC10, during its 919 Futurist Day and Shareholder Community Day held in Los Angeles [1][3] - The investment is led by Faraday Future, with participation from its founder and Co-CEO Jia Yueting, along with other investors including Binance Labs, Sequoia Capital, IDG, and Circle-supported SIGN Foundation [3] - The strategic investment is expected to exceed $41 million, subject to shareholder approval and other closing conditions, with Jia Yueting committing $4 million as a cornerstone investor and voluntarily locking up shares for two years [3] Group 2 - Jia Yueting plans to establish a second creditor trust, allocating 50% of the equity incentives received from his Co-CEO position and half of the profits from the $4 million investment after repaying the loan and related costs to the trust for debt repayment and vehicle manufacturing [3]